Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,142.85
-7.0000-0.61%
Post-market: 1,143.600.7540+0.07%19:59 EDT
Volume:2.05M
Turnover:2.35B
Market Cap:1.08T
PE:38.36
High:1,164.92
Open:1,153.82
Low:1,136.66
Close:1,149.85
52wk High:1,292.65
52wk Low:783.85
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.92
T/O Rate:0.22%
Dividend:6.69
Dividend Rate:0.59%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:31.89
PE(LYR):49.80

Loading ...

Eli Lilly: Calling on Entities That Sellers Use to Conduct Their Illegal Business-Social Media and E-Commerce Platforms

THOMSON REUTERS
·
Aug 12

Eli Lilly - Reports over 14,000 Unlawful Retatrutide Listings in 100 Countries

THOMSON REUTERS
·
Aug 12

Eli Lilly SVP Finance & CAO Donald A. Zakrowski Lepas 2.000 Saham Senilai USD 2,37 Juta

Reuters
·
Aug 12

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Rothschild & Co Redburn Adjusts Eli Lilly and Co. PT to $915 From $900, Keeps Neutral Rating

MT Newswires Live
·
Aug 12

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly

Morning Star
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Eli Lilly's Foundayo Gains First European Approval, Igniting Global Oral Weight-Loss Drug Battle

Deep News
·
Aug 11

What Does Eli Lilly (LLY) Gain From Its Oncology Push And New Funding Bet?

Simply Wall St.
·
Aug 11

MHRA authorizes Eli Lilly’s weight loss pill Foundayo in UK

TIPRANKS
·
Aug 11

Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement

TradingKey
·
Aug 11

Movement Alert|Eli Lilly Rises 3.02% in Regular Trading, Oral GLP-1 Drug Gains First European Approval in UK

Market Focus
·
Aug 11

Eli Lilly Rises After UK Regulator Approves Weight-Loss Drug

Reuters
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

UK Green Lights Lilly's Obesity Pill

Reuters
·
Aug 10

UK’s MHRA Authorises Orforglipron for Weight Management and Type 2 Diabetes

Reuters
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10

Nvidia, Eli Lilly, and Disney Show It's Time to Back the Top Dogs

Dow Jones
·
Aug 10

Eli Lilly and Company Just Beat Revenue By 11%: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
Aug 08

Form 144 | ELI LILLY Officer Hakim proposes to sell 10000 Shares, with a total value of approximately $11.9 Million.

Filings Track
·
Aug 07